Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection.

Journal of cardiovascular medicine (Hagerstown, Md.) - 1 May 2016

Deidda Martino, Madonna Rosalinda, Mango Ruggiero, Pagliaro Pasquale, Bassareo Pier P, Cugusi Lucia, Romano Silvio, Penco Maria, Romeo Francesco, Mercuro Giuseppe

Abstract excerpt

Despite advances in supportive and protective therapy for myocardial function, heart failure caused by various clinical conditions, including cardiomyopathy due to antineoplastic therapy, remains a major cause of morbidity and mortality. Because of the limitations associated with current therapies, investigators have been searching for alternative treatments that can effectively repair the damaged heart and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cardiotoxicity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Heart Failure

Share to Neoplasms

Share to Stem Cell Transplantation

Source

Identifiers

PMID: 27183528
DOI: 10.2459/JCM.0000000000000373

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection.PMID 27183528Read ↗

Anthracycline-mediated cardiomyopathy: Basic molecular knowledge for the cardiologistSemantic proximity Read ↗

Heart Failure in Relation to Anthracyclines and Other Chemotherapies.Semantic proximity Read ↗

Epigenetic Changes Associated With Anthracycline‐Induced CardiotoxicitySemantic proximity Read ↗

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced CardiotoxicitySemantic proximity Read ↗

Pathophysiology of anthracycline cardiotoxicity.Semantic proximity Read ↗

MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage responseSemantic proximity Read ↗

Alteration of cardiac energetics and mitochondrial function in doxorubicin‑induced cardiotoxicity: Molecular mechanism and prospective implications (Review)Semantic proximity Read ↗

Doxorubicin-Induced Cardiotoxicity in Breast Cancer: Mechanistic Pathways, Pharmacogenomic Modifiers, and Translational Strategies.Semantic proximity Read ↗

Role of Oxidative Stress in the Mechanisms of Anthracycline-Induced Cardiotoxicity: Effects of Preventive Strategies.Semantic proximity Read ↗

Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stressSemantic proximity Read ↗

Doxorubicin cardiotoxicity and target cells: a broader perspectiveSemantic proximity Read ↗

Mitochondrial Dysfunction in Cardiac Diseases: Insights into Pathophysiology and Clinical OutcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.